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Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene
EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the
neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identiﬁed 39 different EPG5 mutations, most of them
truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations
(p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with
marked hypotonia and feeding difﬁculties. In addition to the ﬁve principal features (callosal agenesis, cataracts, hypopigmentation,
cardiomyopathy, and immune dysfunction), we identiﬁed three equally consistent features (profound developmental delay, pro-
gressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a speciﬁcity of 97%, and a
sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical
progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24
months (95% conﬁdence interval 0–49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes
were signiﬁcantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent
p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative com-
ponent superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing
EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradio-
logical features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and,
less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included ﬁbre size variability,
central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities.
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Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients
conﬁrmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5
(CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related
Vici syndrome deﬁnes a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features
in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates
an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deﬁ-
cient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.
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Introduction
Vici syndrome (OMIM 242840) is a severe, early-onset neu-
rodevelopmental disorder characterized by the key features of
callosal agenesis, cataracts, cardiomyopathy, generalized hypo-
pigmentation, and combined immunodeﬁciency. Since its rec-
ognition as a distinct entity (Vici et al., 1988), additional case
reports have suggested an extended phenotype including sen-
sorineural hearing loss, a skeletal myopathy, and other, more
variable multi-systemic features (del Campo et al., 1999;
Chiyonobu et al., 2002; Miyata et al., 2007, 2014; Al-
Owain et al., 2010; Rogers et al., 2011; Finocchi et al.,
2012; Ozkale et al., 2012; Said et al., 2012; Cullup et al.,
2013; Ehmke et al., 2014; Filloux et al., 2014).
In 2013, our team linked Vici syndrome to recessive muta-
tions in EPG5 on chromosome 18q (Cullup et al., 2013),
encoding ectopic P-granules autophagy protein 5 (EPG5)
with a key role in autophagy in multicellular organisms
(Tian et al., 2010). Autophagy is a highly conserved lysosomal
degradative pathway, with important roles in cellular homeo-
stasis including infection defence, quality control of proteins
and organelles, and metabolic adaptation (for review see
Mizushima, 2007; Levine and Kroemer, 2008; Klionsky
et al., 2012). The autophagy pathway involves several tightly
regulated steps, evolving from the initial formation of isolation
membranes (or phagophores) to autophagosomes, whose
fusion with lysosomes results in the ﬁnal structures of degrad-
ation, autolysosomes. The EPG5 protein has been implicated
in the penultimate autophagy stages in Caenorhabditis elegans
(Tian et al., 2010) and, more recently, in human cells, sug-
gesting that EPG5 deﬁciency results in failure of autophago-
some-lysosome fusion (Cullup et al., 2013) and, ultimately,
impaired cargo delivery to the lysosome.
Implication of the autophagy pathway in early-onset neu-
rodevelopmental disorders such as Vici syndrome,
Niemann-Pick type C and Lafora disease (Ebrahimi-
Fakhari et al., 2014), and adult-onset neurodegenerative
disorders such as dementia, amyotrophic lateral sclerosis,
and Parkinson’s disease (Nixon, 2013) suggests an
intriguing link between these groups of conditions and em-
phasizes the crucial importance of normally functioning
autophagy for both neuronal formation and maintenance.
A particular link between EPG5 deﬁciency, neurodevelop-
ment, and neurodegeneration is also suggested by the ob-
servation of defective autophagy and neurodegenerative
features resembling human ALS in the Epg5 knockout
mouse (Zhao et al., 2013a, b).
The relative frequency of speciﬁc clinical features, natural
history, overall prognosis, and genotype–phenotype correl-
ations have not yet been reported for EPG5-related Vici
syndrome.
Here we report genetic, clinical, neuroradiological, and
neuropathological features of 50 patients from 30 unrelated
families with EPG5-related Vici syndrome (including 33
previously unreported cases). To further investigate the
functional effects of EPG5 deﬁciency on autophagy and
neuronal function, we studied the effects of conditional
EPG5 knockdown in neurons of the fruit ﬂy, Drosophila
melanogaster, a widely used model for the study of neuro-
degenerative disease (Marsh and Thompson, 2006).
Materials and methods
Patients
Patients were identiﬁed over a 3-year period through the diagnos-
tic service for EPG5-related Vici syndrome and related disorders
at Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust,
UK, and other participating centres offering diagnostic EPG5 test-
ing. Inclusion criteria for diagnostic EPG5 testing at the Guy’s
and St. Thomas’ diagnostic laboratory were patients with ‘Vici
syndrome’ (deﬁned by the presence of at least four out of the ﬁve
key features, i.e. callosal agenesis, cataracts, cardiomyopathy,
hypopigmentation and combined immunodeﬁciency) and patients
with ‘Vici-like syndromes’ (deﬁned by the presence of three or
fewer of the ﬁve key features) as documented on our referral
form (Supplementary material). Additional inclusion criteria for
this study were identiﬁcation of at least one pathogenic mutation
in the EPG5 gene (conﬁrmed Vici syndrome), or presence of the
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clinical phenotype and genetic conﬁrmation of an EPG5 mutation
in a relative with similar features (probable Vici syndrome). The
only exclusion criterion for the present EPG5 genotype–pheno-
type study was the failure to identify at least one pathogenic
EPG5 mutation in patients or an affected relative.
The study was approved and performed under the ethical
guidelines issued by the participating institutions for clinical
studies. Parents/guardians provided written informed consent
for genetic analysis and consented to use of the clinical data in
anonymized forms, and to the publication of recognizable clin-
ical photographs where applicable. Research ethics committee
approval was obtained for transfer and biobank storage of
specimen (blood, ﬁbroblasts, muscle, nerve) for research pur-
poses (REC Reference 06/Q0406/33).
Data were extracted from the questionnaire by two re-
searchers (S.B., H.J.). Data analysis was carried out using
SPSS 22. Parametric tests were performed where the data
were normally distributed, and non-parametric tests were
used if the data were not normally distributed. Survival ana-
lysis was carried out using univariable and multivariable sur-
vival analysis. Censor date was set as the last date that
information was available on the clinical status of the patient
(i.e. alive or deceased). Statistical signiﬁcance was set at
P50.05.
Genetic testing
Genomic DNA was extracted from peripheral blood leucocytes
according to standard procedures. Diagnostic screening for
EPG5 mutations at Guy’s Hospital, Guy’s and St Thomas’
NHS Foundation Trust, UK, was performed by bidirectional
Sanger sequencing as previously described (Cullup et al.,
2013). Assessment of pathogenicity of novel EPG5 variants
was carried out using bioinformatics software Alamut v.2.0.
Clinical information
This was a retrospective, cross-sectional study of all cases with
a diagnosis of conﬁrmed or probable EPG5-related Vici syn-
drome referred to our diagnostic service and other participat-
ing centres over a 3-year period. Clinical data are reported for
the 38 genetically conﬁrmed cases.
Data were obtained from case notes held at the respective
referral centres and previous publications (where applicable),
and collected based on the items included in the referral form
for diagnostic EPG5 sequencing in our laboratory
(Supplementary material).
Neuroradiological features
Brain imaging was performed in 46 patients, and 18 MRI
brain scans were available for review. All available MRI
brain scans were reviewed and analysed by two experienced
paediatric neuroradiologists (J.M.U.K., A.S.) in consensus.
Neuropathological features
Muscle biopsies were performed in 17 children, and one pa-
tient each had a nerve (Patient 18.1), liver (Patient 16.1), bone
marrow (Patient 16.1) and skin (Patient 25.1) biopsy for ultra-
structural examination. Four patients underwent a post-
mortem examination, three of them previously reported
(Vici et al., 1988; Rogers et al., 2011; Miyata et al., 2014).
Pathological samples obtained during life and post-mortem
specimens were reviewed by experienced pathologists (I.B.,
C.A.S., P.B., C.L.).
Generation and characterization
of a conditional epg5 Drosophila
knock-down
Drosophila strains used included: w1118, CG-Gal4, GMR-
Gal4, Ubi-Gal80ts, UAS-Epg5IR(TRiP GL00468), UAS-
GFP::Atg8a, UAS-mRFP. Semi-thin sections and analysis of
adult retina neurons were performed as previously reported
(Nisoli et al., 2010). All crosses and experiments were per-
formed at 25C. Third instar larvae were starved 6 h in
PBS + 20% sucrose to induce autophagy. Fat bodies were dis-
sected, mounted in Vectashield (Vectorlabs) and readily
imaged on a confocal microscope (Zeiss) (Joffre et al., 2015).
Results
General findings
This series includes 50 patients from 30 families with
EPG5-related Vici syndrome; 33 patients from 17 families
are reported here for the ﬁrst time. Thirty-eight had genet-
ically conﬁrmed Vici syndrome and in 12 additional pa-
tients, the diagnosis of Vici syndrome was assumed based
on suggestive features and conﬁrmation of the genetic diag-
nosis in an affected relative. Males (n = 24) and females
(n = 26) were almost equally represented.
Genetic results
We identiﬁed a total of 39 different EPG5 mutations in 38
patients from 30 families of varying ethnicity (Table 1 and
Fig. 1).
Nineteen of these mutations have not been previously
reported. In 12 additional affected cases from the same
families, the EPG5 genotype was assumed, based on the
criteria outlined above. None of the novel EPG5 mutations
identiﬁed were found on publically available databases of
human genetic variation (dbSNP version 135, www.
1000genomes.org/; 1000 Genomes database, www.ncbi.
nlm.nih.gov/projects/SNP/; Exome Variant Server, evs.gs.
washington.edu/EVS/), except for EPG5 p.Gln336Arg
documented in one heterozygous individual on the NCBI
SNP database. Where performed, co-segregation studies
were compatible with recessive inheritance. Twenty-one of
38 (55%) patients were homozygous and 17/38 (45%) of
patients were compound heterozygous for EPG5 muta-
tions. While biallelic inheritance was thus conﬁrmed in
98% of patients with EPG5-related Vici syndrome, in
one case, included because of diagnostic clinical features
(Patient 16.1), only one heterozygous but clearly patho-
genic EPG5 mutation was identiﬁed. Copy number testing
was not performed in this patient. The vast majority of
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EPG5 mutations were predicted to result in a truncated
EPG5 protein, with only a small number of missense mu-
tations identiﬁed. Most mutations were private, with the
exception of three recurrent mutations,
p.Met2242CysfsX5 identiﬁed in the heterozygous state in
an Italian and in the homozygous state in an unrelated
Maltese patient without known parental consanguinity,
p.Arg417X identiﬁed in the homozygous state in a patient
from the Middle East and in the heterozygous state in a
Caucasian child from the USA, and p.Gln336Arg identiﬁed
in the homozygous (n = 3) and in the heterozygous (n = 1)
state in four unrelated patients with deﬁnite or possible
Ashkenazi ancestry.
Family history
Parental consanguinity was reported in 43% (13/30) of
families, corresponding to the large number of homozygous
EPG5 mutations identiﬁed in our cohort. A family history
of suspected Vici syndrome (or an undiagnosed multisystem
disorder with suggestive features) in an already deceased
relative was reported in nine families before the genetic
diagnosis in the index case had been established. We also
noted a high frequency of twin pregnancies, with three
probands having a family history of multiple births, and
two sets of affected children being twins (one set identical,
one set fraternal).
In families currently still under active follow-up (n = 22
families) we obtained more detailed histories
(Supplementary Table 1), which suggested a relatively
high incidence of cancer. A ﬁrst-degree relative of one of
the EPG5-mutated patients developed early-onset cataracts,
and vitiligo was occasionally reported. There was also a
history of neurodegenerative disorders, in particular
Parkinson’s disease, in 2 of 22 families under ongoing
follow-up.
Clinical features
The main clinical ﬁndings and their relative frequencies in
genetically conﬁrmed cases with EPG5-related Vici syn-
dromes are summarized in Table 2 and outlined in more
detail below, and in Supplementary Table 2. Typical clin-
ical features are illustrated in Fig. 2.
Perinatal history
Presentation was mainly neonatal with profound hypotonia
and associated respiratory and bulbar involvement. Some
mothers had reported reduced foetal movements. Few af-
fected neonates had arthrogryposis (n = 6), and/or cleft
palate (n = 3), and/or minor dysmorphic features such as
second and third toe syndactyly (n = 2). Head circumfer-
ence and weight were within the expected centiles for ges-
tational age at birth but both progressively declined over
the course of the ﬁrst year of life (Supplementary Fig. 1).
Developmental history
All children were profoundly delayed. Most children did
not achieve head control. Only four children learned to
roll over; all four subsequently lost this skill. None
achieved independent sitting. Development of social and
communication skills was also profoundly delayed, with
some affected infants acquiring social smile; those who
did subsequently lost this skill. Speech was universally
absent, although a number of children could make
sounds. Two of the older children were reported to be
able to answer simple yes/no questions with gestural
responses.
General features
Failure to thrive was virtually universal, with weight within
the normal range at birth (2nd to 75th centile), but subse-
quently dropping below the third centile despite adequate
caloric intake. Most children required gastrostomy tube
feeding. Fewer than 10% of children gained a normal
body weight despite adequate feeding with parenteral
nutrition.
Neurological and neuromuscular features
An associated seizure disorder was present in 59% of cases
where information was available (20/34). Seizures com-
prised early-onset epileptic encephalopathies with burst-
suppression on EEG and infantile spasms with EEG fea-
tures compatible with hypsarrhythmia and, with few excep-
tions, were difﬁcult to control despite exhaustive treatment
trials with various anticonvulsants. Seizure types varied
from apnoeic seizures, to myoclonic jerks, to tonic-clonic
seizures. The epilepsy syndrome was described as ‘Lennox-
Gastaut-like’ in two cases. EEG discharges were often
multifocal. Where epilepsy was a feature, onset was
within the ﬁrst year of life.
Marked hypotonia with associated generalized weakness,
paucity of movement, gross motor developmental delay,
and mildly but consistently elevated creatine kinase (CK)
levels (median 450 IU/l; IQR 420–930 IU/l; range 314–
1400 IU/l) suggested a concomitant skeletal myopathy, con-
ﬁrmed in 17 patients on pre-mortem muscle biopsy (see
below). Deep tendon reﬂexes were reduced or absent in
most cases. Seven patients had EMG/nerve conduction stu-
dies, six of which demonstrated evidence of a myopathy.
Despite a normal head circumference at birth, microceph-
aly was subsequently reported in 90% of children where
measurements were available (28/31) (Supplementary Fig.
1). One older patient showed features of an evolving dys-
tonic-choreoathetoid movement disorder and in another a
spastic quadriparesis was diagnosed, although the latter
may have been related to a secondary hypoxic insult.
Ocular and auditory features
Seventy-six per cent (29/38 genetically conﬁrmed cases) of
patients had cataracts, either at birth or evolving over the
ﬁrst months of life. Optic atrophy and retinal changes were
present in 11 and 14 patients, respectively. Five children
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had ocular albinism. Ten patients had formal neurophysio-
logical visual assessment by visual evoked potential/electro-
retinogram, of which almost all (8/10) were abnormal.
Neuro-ophthalmological features from one patient have
been previously reported in detail (Filloux et al., 2014),
and included retinal hypopigmentation, poor foveal devel-
opment, b-wave amplitudes in the lower normal range on
ERG, and probable misrouting at the optic chiasm similar
to what has been described in typical albinism. Brain audi-
tory evoked responses provided evidence for sensorineural
hearing impairment in six of nine patients where
performed.
Additional multisystem involvement
Heart
Most children had a hypertrophic and/or dilated cardiomy-
opathy (82%, 28/34); this was not always present in the
ﬁrst months of life, however, the cardiomyopathy appeared
to be progressive where consecutive cardiac ultrasounds
were performed (Supplementary Table 3). Intermittent de-
terioration of cardiac function associated with intercurrent
illness was also observed. Structural congenital heart
abnormalities comprising patent foramen ovale, ventricular
or atrial septal defects, hypoplastic aortic arch or mitral
valve insufﬁciency were found in 10 children.
Skin
Generalized skin and hair hypopigmentation was present in
most patients, always relative to familial and ethnic back-
ground. In a number of children (n = 6), unexplained inter-
mittent maculo-papular rashes were also noted.
Immune system
All patients (38/38) had recurrent and unusual infections
suggestive of an underlying immunodeﬁciency, most fre-
quently recurrent pneumonia. Infective agents cultured
included Streptococcus viridans, Staphylococcus hominis,
Klebsiella, Pseudomonas, and Candida albicans. In add-
ition, recurrent unexplained pyrexias without identiﬁcation
of a pathogenic organism were also a feature. A large
Table 1 EPG5 mutations in patients with Vici syndrome
Family Origin Ethnicity Consanguinity Mutation 1 Mutation 2
Nucleotide Amino acid Exon Nucleotide Amino acid Exon
1 Italy Caucasian No c.4588C4T p.Gln1530* 26 c.5704dupT p.Tyr1902Leufs*2 33
2 Italy Caucasian No c.2413-2A4G c.6724delA p.Met2242Cysfs*5 39
3 UK British-Asian No c.1253-1G4T c.5110-1G4C
4 Germany Turkish Yes c.4952 + 1G4A p.Phe1604Glyfs*20 28 c.4952 + 1G4A p.Phe1604Glyfs*20 28
5 Netherlands Turkish Yes c.3481C4T p.Arg1161* 19 c.3481C4T p.Arg1161* 19
6 USA Caucasian No c.5835T4A p.Cys1945* 33 c.1370T4C p.Leu457Pro 4
c.2351A4C p.Gln784Pro 12
7 USA Caucasian Yes c.1007A4G p.Gln336Arg 2 c.1007A4G p.Gln336Arg 2
8 USA Caucasian No c.2575G4T p.Glu859* 14 c.6232C4T p.Arg2078* 37
9 Saudi Arabia Arabic Yes c.4751T4A p.Leu1584* 27 c.4751T4A p.Leu1584* 27
10 Japan Japanese No c.2719-1G4A c.6295dupA p.Ser2099Lysfs*5 37
11 Malta Caucasian No c.6724delA p.Met2242Cysfs*5 39 c.6724delA p.Met2242Cysfs*5 39
12 USA Caucasian No c.6005_6006dupAG p.Leu2003Serfs*30 35 c.6112T4C p.Cys2038Arg 36
13 UAE Arabic Yes c.4783C4T p.Gln1595* 27 c.4783C4T p.Gln1595* 27
14 Egypt Arabic Yes c.2355delC p.Arg786Glufs*10 12 c.2355delC p.Arg786Glufs*10 12
15 Israel Israeli-Arabic Yes c.5993C4G p.Ser1998* 35 c. 5993C4G p.Ser1998* 35
16 UK Caucasian No c.1007A4G p.Gln336Arg 2 ? ?
17 Germany Turkish Yes c.1278delC p.Ser427Leufs*6 4 c.1278delC p.Ser427Leufs*6 4
18 Australia/Greece Caucasian Yes c.7333C4T p.Arg2445* 42 c.7333C4T p.Arg2445* 42
19 UAE Arabic Yes c.1249C4T p.Arg417* 3 c.1249C4T p.Arg417* 3
20 Italy Caucasian No c.7447C4T p.Arg2483* 43 c.1435_1438delCTTC p.Leu479* 5
21 Oman Arabic Yes c.6084G4A p.Trp2028* 36 c.6084G4A p.Trp2028* 36
22 Saudi Arabia Arabic Yes c.3693G4A p.Gln1231Gln 20 c.3693G4A p.Gln1231Gln 20
23 Germany Caucasian No c.5869 + 1G4A c.5966G4A p.Trp1989* 35
24 USA Caucasian No c.136C4T p.Gln46* 2 c.6275T4C p.Leu2092Pro 37
25 Brazil Caucasian No c.3481C4T p.Arg1161* 19 c.6280delG p.Glu2094Lysfs*23 37
26 Israel Ashkenazi Yes c.1007A4G p.Gln336Arg 2 c.1007A4G p.Gln336Arg 2
27 USA Caucasian No c.2542delC p.Gln848Argfs*25 13 c.3493_3497delATCCT p.Ile1165Leufs*8 19
28 Israel Israeli-Arabic Yes c.3447C4T p.Trp1149* 19 c.3447C4T p.Trp1149* 19
29 USA Ashkenazi No c.1007A4G p.Gln336Arg 2 c.1007A4G p.Gln336Arg 2
30 USA Caucasian No c.1249C4T pArg417* 3 c.7240G4A p.Glu2414Lys 42
EPG5 mutations/variants described according to HGVS guidelines and transcript reference NM_020964.2. Stop mutations are indicated by an asterisk. EPG5 mutations in Families 1–
13 have been previously reported in Cullup et al. (2013), EPG5 mutations in Families 14–30 are reported here for the first time. In Family 16, only one heterozygous pathogenic EPG5
variant was identified in the proband. The splicing change indicated in Family 4 was derived from cDNA sequencing. The c.3693G4A (p.Gln1231Gln) sequence variant identified in
Family 22 occurs at the last base of the exon and is expected to cause aberrant splicing of the EPG5 transcript.
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abscess developed after varicella vaccination in one child,
requiring surgery. Where formal assessment of immune
function was performed (n = 11), this suggested a combined
immunological defect with both T and B cells being af-
fected. One child had normal immunological studies, an-
other (Patient 25.1) was diagnosed with severe combined
immunodeﬁciency. In four cases intravenous immunoglobu-
lin was reported to be of beneﬁt (Finocchi et al., 2012).
Haematological abnormalities were present in 24 patients,
with anaemia, and leucopaenia commonly reported.
Other organ systems
Variable additional organ involvement concerned thyroid,
thymus, lungs, liver, and kidneys and comprised both de-
fects of organ formation (e.g. thyroid agenesis, thymus
aplasia, pulmonary hypoplasia) and function (e.g. hypothy-
roidism, electrolyte disturbance). A peculiar feature in six
patients was intermittent episodes of profound electrolyte
disturbance (mainly hypokalaemia) suggestive of renal
tubular dysfunction, as reported previously in one case
(Miyata et al., 2007).
Progression and prognosis
Vici syndrome is a severe, life-limiting condition. Survival
analysis demonstrated that the median survival time was 24
months [95% conﬁdence interval (CI) 0–39 months], with
only a tenth of patients surviving to 5 years of age. Twelve
patients were still alive at the censor date, and the oldest
living patient is 10 years old. Cardiorespiratory failure in
the context of a respiratory tract infection and/or immuno-
deﬁciency was indicated as the most common cause of
death.
Genotype–phenotype correlations
As most of the EPG5 mutations identiﬁed were distributed
throughout the entire EPG5 coding sequence and private to
individual families, precise genotype–phenotype correl-
ations are difﬁcult to establish. However, analysing survival
time until death or censor date, we could establish that
patients with homozygous mutations died at a median
age of 9 months compared to 48 months in patients with
heterozygous EPG5 mutations (P = 0.046) (Supplementary
Fig. 2). Compared to patients with truncating EPG5 muta-
tions, patients homozygous (n = 3) or compound heterozy-
gous (n = 1) for the recurrent p.Gln336Arg mutation, one
of the few missense mutations identiﬁed in our cohort, had
a longer life expectancy with a median survival of 78
months. Whether this observation is due to the expression
of a missense mutant protein conferring residual function,
Figure 1 Distribution of disease-causing mutations in EPG5. The EPG5 gene is represented, with the 44 exons depicted as grey vertical
bars (exons 1, 10, 25, 35 and 44 are numbered for orientation). The exon position of Vici-causing mutations are indicated by the arrows, with the
mutation details listed at the arrow tail. Mutations found in two or more unrelated patients due to possible founder effects are coloured red.
EPG5 mutations/variants described according to HGVS guidelines and transcript number NM_020964.2.
Table 2 Clinical features of EPG5-related Vici syndrome
Feature %
Principal diagnostic features
Absent corpus callosuma 100
Gross developmental delayb 100
Immune problemsa 100
Failure to thriveb 97
Pale skin/light haira 95
Microcephalyb 90
Cardiomyopathya 82
Cataractsa 76
Other prominent features
Neonatal presentation 87
Seizures 59
Clinical features and their relative frequencies compiled from genetically confirmed
cases of Vici syndrome in this series (n = 38).
aOriginal diagnostic feature.
bNew diagnostic feature identified in this series.
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or partial impairment of EPG5 splicing (p.Gln336 is the
last amino acid of its exon and the mutation c.1007A4G is
predicted to abolish the donor splice site) (Cullup et al.,
2013) is currently uncertain. Interestingly, two of the pa-
tients with the p.Gln336Arg mutation had not developed
cataracts, and three did not have cardiomyopathy at the
censor date.
Binary logistic regression was used to compare the
number of eight key features identiﬁed (absent corpus cal-
losum, cataracts, hypopigmentation, cardiomyopathy,
immune dysfunction, profound developmental delay, pro-
gressive microcephaly, failure to thrive), with the likelihood
of a positive EPG5 genetic test in all 66 patients tested (36
EPG5-positive, 30 EPG5-negative), indicating that the
presence of all eight features had a speciﬁcity of 97%,
and a sensitivity of 89% for a positive EPG5 genetic test.
Neuroradiological features
Brain MRI scans were available for review from 18 chil-
dren in our series with EPG-related Vici syndrome. Key
neuroradiological features are illustrated in Fig. 3 and sum-
marized in Supplementary Table 4.
Complete agenesis of the corpus callosum was present on
all MRI scans reviewed and was also reported on brain
MRI, CT, and/or cranial ultrasound in the remaining pa-
tients for whom scans were unavailable for review.
Colpocephaly was consistently associated with callosal
agenesis, often with asymmetric dilation of the posterior
aspect of the lateral ventricles. The pons invariably ap-
peared hypoplastic relative to the cerebellum and remainder
of the brainstem. The cerebellar vermis was generally well
formed, with only two patients showing minor deﬁciency of
Figure 2 Clinical features of EPG5-related Vici syndrome. Clinical photographs from Patient 5.2 (A), Patient 3.1 (B), Patient 2.1 (C),
shown with Professor Carlo Dionisi Vici, the original describer of Vici syndrome, Patient 23.1 (D), Patient 24.2 (E) and Patient 16.1 (F and G) at
different ages. There is marked hypopigmentation, never absolute but always relative to the familial and ethnic background [Patient 5.2 (A) and
Patient 3.1 (B) were of Turkish and British-Indian parentage, respectively]. Cataracts may be either present from birth (B, note reduced red reflex
in the right eye) or develop over the first year of life. Some patients may have myopathic facial features (D, note tent-shaped mouth) and/or other
clinical signs of a skeletal muscle myopathy. Few patients may have coarse facial features reminiscent of a lysosomal storage disorder, either
present from birth (B) or developing with increasing age. Although head circumference is consistently normal at birth, all patients with EPG5-
related Vici syndrome ultimately manifest microcephaly over time (C and E). In some patients, a recurrent, often confluent maculo-papular rash
(F and G) was noted.
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the inferior vermis. Mild prominence of the cisterna magna
was seen in few cases but other recognized cystic malfor-
mations of the posterior fossa were not observed. Five pa-
tients showed diffusely abnormal low T2 signal within the
thalami, with additional diffuse T1 hyperintensity in one of
those cases. Thalamic changes were associated with older
age at MRI (median age of 27 months in those with, com-
pared to 8.5 months in those without thalamic changes,
P = 0.04). The basal ganglia were otherwise normally
formed in all patients. Neuromigrational abnormalities
were not a signiﬁcant feature, although two patients
showed mild simpliﬁcation of sulcation pattern for age.
Myelination was delayed for age in all patients. White
matter bulk was reduced and the Sylvian ﬁssures showed
reduced opercularization to varying degrees in all patients.
Neuropathological features
Ante-mortem muscle biopsies performed in 17 patients re-
vealed a consistently associated myopathy (Supplementary
Table 5), on light microscopy characterized by (in order of
decreasing frequency): increased variability in ﬁbre size,
increased internalized and/or centralized nuclei, type 1 at-
rophy (consistent in some with designation as ﬁbre type
disproportion), increased glycogen storage, type one pre-
dominance, and cores. There was variably increased acid
phosphatase staining localizing to vacuoles, and reddish
staining of some atrophic ﬁbres on the Gomori trichrome
stain, suggesting localized basophilia or mitochondrial
abnormalities. Occasionally, mild dystrophic features with
increase in connective tissue and few regenerating and an-
gular ﬁbres were noted. Where speciﬁc immunohistochem-
ical studies were performed, increase in autophagy marker
proteins (p62, LAMP2) in the region of the vacuoles was
observed. Respiratory chain enzyme studies performed in
seven patients were normal in four but showed variable
reduction of respiratory chain complexes (except complex
II) in the other three.
Ultrastructural examination (Fig. 4) performed in 12 pa-
tients conﬁrmed central localization of nuclei in many
Figure 3 Radiological features of EPG5-related Vici syndrome. (A) Midline sagittal T1 sequence showing complete agenesis of the
corpus callosum. There is moderate-to-severe hypoplasia of the pons (arrow). In contrast, the cerebellar vermis appears well formed. (B) Axial T1
image at level of the body of the lateral ventricles show parallel configuration of the lateral ventricles (asterisk), typical for callosal agenesis.
Moreover, the expected high T1 signal of myelin within the white matter is generally reduced (arrow), in keeping with delay in myelination. (C and
D) Axial T1 and T2 at the level of the thalami show diffuse abnormal low T2 and high T1 signal within the thalamus (asterisk), a feature which has
been reported in lysosomal storage disorders, but was only seen in a small proportion of our cases. There is also reduction in white matter bulk
and reduced opercularization of Sylvian fissures (arrows). Note is made of colpocephaly with prominence of posterior horns of lateral ventricles
(arrowheads), a feature seen with callosal agenesis.
EPG5-related Vici syndrome BRAIN 2016: 139; 765–781 | 773
ﬁbres, corresponding to ﬁndings on light microscopy. There
were variable degrees of subsarcolemmal accumulation of
vacuoles, glycogen and mitochondria. Deposition of debris
within basal lamina layers resembling ultrastructural ﬁnd-
ings in X-linked myopathy with excessive autophagy
(MEAX) (Ramachandran et al., 2013) was commonly
observed, often with evidence of ongoing exocytosis.
Nuclei were often central and surrounded by a ‘ring-
shaped’ mitochondrial arrangement, similar to what has
been described in DNM2-related centronuclear myopathy
(CNM) (Susman et al., 2010). Mitochondria often showed
abnormal size, shape, and internal structure. There was
generalized reduction of often poorly formed myoﬁlaments.
Sarcomeric disarrangements resembling minicores were
seen in one patient.
Sural nerve biopsy performed in one patient showed
almost complete absence of myelinated axons
(Supplementary Fig. 3).
Skin biopsy performed for ultrastructural examination in
one patient showed a reduced number of melanosomes
with a low degree of melanization but no other abnormal-
ities. Other ﬁndings were considered suggestive of neurax-
onal dystrophy as previously reported (Ozmen et al., 1991).
Ante-mortem bone marrow performed in one patient was
normal.
Post-mortem neuropathological examination (Patient
27.1) demonstrated callosal agenesis, hypoplasia of the
pons, and corticospinal tracts as the most striking CNS
abnormalities (Fig. 5). Additional ﬁndings included small
brain size and coarse gyration pattern, hypoplastic hippo-
campi, and a small pons with markedly hypoplastic corti-
cospinal bundles. Bodian silver stains showed a reduced
number of axons within the hippocampus and other struc-
tures (data not shown). A major histopathological ﬁnding
on general post-mortem examination was the presence of
storage material in cardiomyocytes, Purkinje ﬁbres, skeletal
Figure 4 Ultrastructural abnormalities of muscle in EPG5-related Vici syndrome. Muscle biopsies from Patients 4.1 (A–B and D–F)
and 27.1 (C). On electron microscopy, variability in fibre diameter (A) and central nuclei (A and B) often surrounded by a ‘ring-shaped’
mitochondrial arrangement (B) were noted. There was abundant intracellular debris (C), most commonly membrane-bound, often deposited
within basal lamina layers (D) and with evidence of ongoing exocytosis. There was an increase in both free and membrane-bound glycogen in
lysosomes (C and E). There was generalized reduction of often poorly formed myofilaments, admixed with deposited abnormal material (F).
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myocytes, bronchial chondrocytes, enteric smooth muscle
cells, and hepatocytes; this material stained with periodic
acid Schiff (PAS) (resistant to diastase digestion) on histo-
logical sections, indicating a carbohydrate or glycoprotein
component. Electron microscopy demonstrated membrane-
bound autophagic vacuoles containing phospholipid mem-
branes, organelles, in particular mitochondria, and granular
material consistent with glycogen as well as an excess of
free glycogen. Neuropathological and general pathological
ﬁndings on post-mortem were similar to those previously
reported in two of our patients (Rogers et al., 2011; Miyata
et al., 2014).
Conditional epg5 knock-down in
Drosophila
We analysed the progression of autophagy in the
Drosophila larval fat bodies, the equivalent of liver tissue
in the ﬂy, which is fully digested by autophagy during late
larval and pupal stages. Upon starvation for 6 h, large
autophagosomes and autolysosomes marked by
GFP::Atg8a are readily observed in control wild-type
larvae (Fig. 6A) and cellular structures, including nuclei,
are not detectable as they have been degraded. However,
when epg5 (CG14299) is downregulated via the use of the
collagen promoter and the Gal4/UAS expression system
(CG14299-Gal4), large abnormal vacuoles, in which the
GFP signal is quenched, accumulate (Fig. 6A). The shape
of cellular structures, including the nuclei is preserved, indi-
cating a failure in autophagic digestion. Analysis at an ear-
lier time point reveals that autophagosomes initially form
correctly as bright GFP::Atg8a punctae (Fig. 6A), which
then stall and degenerate later on. This is consistent with
defects in the late steps of autophagy after correct initiation
and with a block in digestion of autolysosomes, as previ-
ously reported in EPG5-deﬁcient human cells (Cullup et al.,
2013). Conditional downregulation of epg5 speciﬁcally in
Figure 5 Neuropathological features of EPG5-related Vici syndrome. (A) Gross lateral view of left hemisphere. Note somewhat
indistinct gyral pattern, and relatively prominent sulci for age. The insula is visible, consistent with an opercularization defect, and the Sylvian
fissure extends more posteriorly than normal. (B) Whole-brain section stained with Luxol Fast blue/haematoxylin and eosin (LFB/H&E) at the
level of the thalamus. Note the callosal agenesis, prominent temporal ventricles, and malrotated hippocampi. (C) Hippocampus immunostained for
glial fibrillary acidic protein (GFAP). Most notable is the diminutive size of the fornix and associated reactive gliosis. (D) Transverse brainstem
section at the level of the pons, stained with LFB/H&E. Note the small size of the pons, which is estimated to be less than half its normal volume.
The superior cerebellar peduncles are relatively normal, as is the tegmentum, but the size of the medial lemniscus and corticospinal tracts are
somewhat reduced, albeit less than the pontine grey matter.
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the adult Drosophila retina (using GMR-Gal4 and a tem-
perature-sensitive Gal80) reveals that, despite an intact ret-
inal structure at Day 1 of adult life, loss of neurons and of
retina structure evolves and is detected after 14 days and
28 days (Fig. 6B). Quantiﬁcation of the number of remain-
ing photoreceptor neurons in each ommatidium reveals a
signiﬁcant and incremental loss of cells over time (Fig. 6C).
These data establish that the isolated loss of EPG5 function
causes progressive neuronal degeneration in Drosophila,
mirroring the situation in humans.
Discussion
This is the ﬁrst study to extensively describe genotype–
phenotype correlations in a large cohort of patients with
EPG5-related Vici syndrome, establishing the condition as
a paradigm of neurodevelopmental conditions due to pri-
mary autophagy defects, and a probably not uncommon
but under-recognized multisystem disorder.
EPG5 mutations in our series were found throughout a
wide range of different ethnicities. The vast majority of
EPG5 mutations were private, precluding future targeted
screening of the large EPG5 gene in patients presenting
with suggestive clinical features. We identiﬁed only three
recurrent EPG5 mutations, in families with (possible or
conﬁrmed) Ashkenazi (p.Gln336Arg; n = 4), Maltese-
Italian (p.Met2242CysfsX5; n = 2), and Caucasian or
Middle-Eastern ancestry (p.Arg417X; n = 2), suggesting
the presence of possible founder effects in some popula-
tions. Most EPG5 mutations identiﬁed were single nucleo-
tide substitutions with a predicted truncating effect on the
EPG5 protein (Table 1 and Fig. 1). Identiﬁcation of only
one single pathogenic EPG5 mutation in Patient 16.1
Figure 6 Knock-down of epg5 in Drosophila. (A) Single confocal sections of fat bodies from fed and starved (6 h, unless otherwise indicated)
larvae, either control or bearing RNAi-mediated downregulation of epg5. Red is membrane-bound RFP to highlight the cell membranes, green is
the autophagy marker GFP::Atg8a. Arrows point to large autolysosomes from which GFP::Atg8a fluorescence is quenched on the inside, but is
retained outside. Bottom left is a schematic drawing of an undigested fat body cell. (B) Semi-thin tangential eye sections from either control flies
or flies bearing RNAi-mediated downregulation of epg5 and aged 1, 14, and 28 days at 29C to induce epg5 downregulation. The drawing on top
schematizes the process of cell degeneration and loss in this tissue. Below each section is an exemplary quantification of the photoreceptors in the
ommatidia shown. (C) Graphs displaying the quantification of the number of photoreceptors (PR) in the ommatidia of the flies aged 14 and 28
days. Knock-down of epg5 reduces the ommatidia with a normal number of photoreceptor neurons (7) and this phenotype increases with time
(2 values are 166.5 and 721.6 with P5 0.0001 for 6 degrees of freedom).
776 | BRAIN 2016: 139; 765–781 S. Byrne et al.
suggests the possibility of (compound) heterozygosity or
homozygosity for non-overlapping genomic deletions in
the large EPG5 gene and emphasizes the need to comple-
ment current diagnostic strategies with techniques suitable
to identify pathogenic copy number variations in future.
Locus heterogeneity is another but less likely possibility,
considering that490% of patients presenting with the
key diagnostic features were also found to have biallelic
EPG5 mutations.
Detailed review of the family histories in the 22 families
remaining under follow-up (Supplementary Table 1) re-
vealed a large number of cases of cancer (in particular
breast, stomach, and skin) and, less frequently,
Parkinson’s disease in relatives of patients with EPG5-
related Vici syndrome. These observations are far too lim-
ited to draw any conclusions, especially as the incidence of
cancer is increasing globally and also varies within different
ethnic groups, but should prompt additional systematic
prospective studies, to obtain more robust data concerning
a potential association between the EPG5 carrier state, and
neoplastic and neurodegenerative disorders, respectively. Of
note in this context, EPG5 (known as KIAA1632 at the
time) was initially found to be mutated in breast cancer
(Halama et al., 2007), and there is a precedent of an
increased frequency of Parkinson’s disease in families with
lysosomal storage disorders (for review, see Brockmann
and Berg, 2014). Moreover, an association of an increased
cancer frequency and Parkinson’s disease has also recently
been reported (Feng et al., 2015), further supporting a link
between tumorigenesis and neurodegenerative disorders
linked in similar intracellular quality control pathways.
The disproportionately high rate of (both monozygotic
and dizygotic) twin pregnancies was another interesting
but unexplained observation in our series.
Despite some variability of additional multi-systemic in-
volvement (Supplementary Table 2), there was considerable
homogeneity concerning a set of core clinical features
(Table 2), probably reﬂecting that most EPG5 mutations
are predicted to cause at least partial loss of the EPG5
protein rather than more subtle alterations of functionally
critical domains. In addition to the ﬁve features that have
previously been considered to be diagnostic (McClelland
et al., 2010), we identiﬁed three additional features that
are equally consistent in EPG5-related Vici syndrome and
will help clinicians to make more informed decisions re-
garding genetic testing in suspected cases. The eight diag-
nostic features (Table 2) are highly predictive of EPG5
involvement, with pathogenic EPG5 mutations identiﬁed
in490% of cases where six or more of these features are
present; however, some of these features (in particular cata-
racts, cardiomyopathy and immunodeﬁciency) may only
evolve over time and are not necessarily present from birth.
We also obtained natural history data that will be useful
for future clinical trials, indicating EPG5-related Vici syn-
drome as a severe disorder with a markedly reduced life
expectancy. Although more detailed genotype–phenotype
studies were hampered by the private nature of the
majority of the EPG5 mutations identiﬁed, tentative links
between the class of mutation and the observed phenotype
could be established. Whilst, not unexpectedly, most trun-
cating EPG5 mutations were associated with a severe
phenotype, the only recurrent missense mutation in our
series, p.Gln336Arg, was associated with a reduced likeli-
hood of cataracts or a cardiomyopathy, and a relatively
longer life expectancy. In addition, we demonstrated that
patients with compound heterozygous EPG5 mutations
had longer survival times than those with homozygous
EPG5 mutations. The basis for this observation is currently
unclear but may reﬂect over-representation of truncating
mutations in homozygous compared to heterozygous
patients.
A particular emphasis of this study was on a detailed
characterization of neurological, neuroradiological, and
neuropathological aspects. EPG5-related Vici syndrome
emerged as a profoundly severe neurodevelopmental dis-
order, and our data suggest that acquisition of certain de-
velopmental skills virtually excludes EPG5 involvement
even if some of the other features are present. The ﬁnding
of often severe epilepsy from infancy in two-thirds of pa-
tients puts EPG5 within the rapidly expanding group of
genes associated with early-onset epileptic encephalopa-
thies, and in the context of other conditions, for example
Lafora body disease (Ebrahimi-Fakhari et al., 2014) or
mTOR-related disorders (Lipton and Sahin, 2014), where
severe epilepsy and dysregulation of the autophagy path-
way have been associated. Our data also indicate that the
natural history parallels that of a (neuro)degenerative con-
dition: in those children surviving beyond infancy, there
was progressive loss of skills and profound acquired micro-
cephaly, suggesting that EPG5-related Vici syndrome is as
much a neurodegenerative as a neurodevelopmental dis-
order. Intriguingly, neurodegeneration with mainly parkin-
sonian ﬁndings is also a feature of Chediak-Higashi
(Silveira-Moriyama et al., 2004) and Marinesco-Sjoegren
syndromes (Byrne et al., 2015), neurodevelopmental dis-
orders with overlapping clinical features and linked in
related molecular pathways (see below).
Agenesis of the corpus callosum, one of the original ﬁve
diagnostic features, was found in all patients on systematic
review of brain MRI ﬁndings (Fig. 3 and Supplementary
Table 4) but is not speciﬁc per se and can often be syn-
dromic (McClelland et al., 2010); however, the isolated
combination of callosal agenesis and pontine hypoplasia
without other structural abnormalities is fairly distinct.
Callosal agenesis and pontine hypoplasia has been reported
in the ‘tubulinopathies’ due to mutations in the neuron-
speciﬁc a- and b-tubulin genes (Cushion et al., 2013), how-
ever, additional neuroradiological features (including basal
ganglia abnormalities, cerebellar hypoplasia, and complex
cortical malformations) commonly found in these disorders
were not typically seen in EPG5-related Vici syndrome.
Although pontine hypoplasia was prominent in our series,
cerebellar abnormalities were not as marked as has been
reported in pontocerebellar hypoplasia (Uhl et al., 1998),
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or SNX14-associated cerebellar ataxia and intellectual dis-
ability (Thomas et al., 2014; Akizu et al., 2015). Like
EPG5, SNX14 has a putative role in endosome/autophago-
some interaction with lysosomes, but it is currently uncer-
tain how these functionally similar proteins cause
overlapping, but nevertheless distinct CNS malformations.
In addition to non-speciﬁc features such as delayed mye-
lination, an interesting and previously unreported ﬁnding
was the presence of abnormal low T2 signal in the thal-
amus in ﬁve patients, apparently evolving over time. Similar
thalamic changes have been previously reported as a rela-
tively speciﬁc feature of lysosomal storage disorders (Autti
et al., 2007). Taken together with overlapping clinical and
histopathological features, these ﬁndings provide further
evidence that primary autophagy disorders, such as Vici
syndrome and primary lysosomal storage disorders, are in-
tricately linked in the same pathogenic mechanisms, as has
been suggested previously (Settembre et al., 2008).
Systematic analysis of muscle biopsy ﬁndings (Fig. 4 and
Supplementary Table 5) conﬁrmed a skeletal myopathy,
previously documented in more detail in only two cases
(Al-Owain et al., 2010; McClelland et al., 2010), as a con-
sistently associated ﬁnding. Whilst numerous vacuoles on
both light and electron microscopy are the most ominous
ﬁnding and deﬁne the EPG5-related skeletal muscle myop-
athy as a primary vacuolar myopathy, vacuoles can be
absent or inconspicuous and other features may be equally
or more prominent, including marked variability in ﬁbre
size with type 1 predominance and atrophy (ﬁbre type dis-
proportion), increase in internal and centralized nuclei, and
increased glycogen storage. In few cases we also observed
focal areas of sarcomeric disorganization, resembling mini-
cores, suggesting an overlap with the core myopathies
(Jungbluth et al., 2011). Respiratory chain enzyme abnorm-
alities were another novel observation in four patients, sup-
porting secondary mitochondrial dysfunction, already
suggested by abnormalities of mitochondrial internal struc-
ture and positioning reported in earlier studies (Cullup
et al., 2013), as a possible downstream effect of defective
autophagy. Based on the observations above, histopatholo-
gical features in EPG5-related Vici syndrome may mimic a
number of primary neuromuscular disorders, in particular
the vacuolar myopathies (Malicdan and Nishino, 2012)
and centronuclear myopathies (Jungbluth et al., 2008), con-
ditions that, interestingly, have been linked with primary
and secondary defects of the autophagy pathway
(Jungbluth and Gautel, 2014). The defects implicated in
Danon disease (Nishino et al., 2000) and X-linked myop-
athy with excessive autophagy (MEAX) (Ramachandran
et al., 2013), in particular impaired autolysosomal fusion
and defective intralysosomal digestion, affect the same part
of the autophagy pathway also affected in EPG5 deﬁciency.
Considering common features of increased glycogen storage
and mitochondrial abnormalities, EPG5-related Vici syn-
drome also ought to be considered in genetically unresolved
‘glycogen storage’ or ‘mitochondrial’ disorders suspected on
histopathological grounds.
The differential diagnosis of EPG5-related Vici syndrome
includes a number of syndromes with overlapping clinical
features. Marinesco-Sjoegren syndrome and related dis-
orders share cataracts and a skeletal myopathy with or
without sensorineural deafness; however, acquired micro-
cephaly and profound failure to thrive are not common
features and the overall degree of developmental delay is
usually less severe (Krieger et al., 2013). Hypopigmentation
and immune defects are also features of Chediak-Higashi
syndrome and related primary immunodeﬁciency syn-
dromes. Chediak-Higashi syndrome also features neuro-
ophthalmological similar to those seen in EPG5-related
Vici syndrome (Filloux et al., 2014), indicating that both
conditions belong to the same group of syndromic
albinism.
The multitude of symptoms associated with EPG5-
related Vici syndrome reported in the present study impli-
cates the autophagy pathway in the normal formation and
functioning of a wide range of organ systems (brain, eye,
hearing, heart, lung, liver, kidney, immune system, blood)
and, by proxy, organ-speciﬁc disease. While in some of
these organs a role of the autophagy pathway is already
recognized, in others such a role has not yet been con-
sidered. A striking and previously unrecognized feature in
our series was profound failure to thrive despite adequate
calorie intake, with almost all patients dropping below the
0.4th centile for weight within the ﬁrst year of life. Low
weight, probably due to reduced adipose tissue or reduced
muscle mass, is also a feature in Epg5 knockout mice
(Zhao et al., 2013a), suggesting a speciﬁc association
with EPG5 deﬁciency.
Our observation of a common occurrence of structural
and degenerative changes affecting the same organ in the
same patient suggests that EPG5-related Vici syndrome is
as much a disorder of embryonic organ development as of
normal organ function. For example, a substantial propor-
tion of patients in our series had structural congenital car-
diac defects and developed a severe cardiomyopathy later
in life (Supplementary Table 3), probably reﬂecting rapid
accumulation of vacuoles and abnormal material in meta-
bolically highly active cardiomyocytes, as demonstrated on
post-mortem myocardial examination in one family (Rogers
et al., 2011); increased oxidative stress due to accumulation
of damaged mitochondria is possibly a main contributory
component.
The dual effects of defective autophagy on cellular devel-
opment and maintenance in EPG5-related Vici syndrome
are particularly pertinent on the level of the CNS, where
the present study provides evidence for a neurodegenerative
component evolving in the context of a neurodevelopmen-
tal defect, also supported by ﬁndings of a neuropatho-
logical phenotype resembling human amyotrophic lateral
sclerosis in the Epg5 knockout mouse (Zhao et al.,
2013a). A general role of autophagy in neuronal embryo-
genesis is supported by the ﬁnding of severe neural tube
defects in the Ambra1 knockout mouse but remains to be
further elucidated (Cecconi et al., 2007; Fimia et al., 2007).
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Moreover, certain stem cells involved in neurodevelopment
may also have a role in neurodegeneration, suggesting that
defects in the pathways leading to aberrant development
may also result in later neurodegeneration, due to a pleio-
tropic effect of some neurodevelopmental genes on the ner-
vous system (Zhang et al., 2013). These observations place
EPG5-related Vici syndrome within an emerging group of
early-onset neurodevelopmental and neurodegenerative dis-
orders associated with defective autophagy (reviewed in
Ebrahimi-Fakhari et al., 2014, 2015) such as static enceph-
alopathy in childhood with neurodegeneration in adult-
hood (SENDA) due to recessive mutations in WDR45
(Haack et al., 2012), and a recently recognized syndromic
form of early-onset ataxia due to recessive mutations in
SNX14 (Thomas et al., 2014; Akizu et al., 2015).
To explore the effects of EPG5 deﬁciency on neuronal
maintenance, we generated a conditional neuronal
Drosophila knock-down (Fig. 6). First we conﬁrmed that
in Drosophila loss of epg5 function leads to defects in the
autophagic process of digestion of the larval fat bodies
triggered by starvation, which essentially recapitulates the
defects in late events in the autophagy cycle reported in
human cells (Cullup et al., 2013) and validates the use of
Drosophila as a model to study EPG5 function. Drosophila
is widely used for the study of neurodegenerative condi-
tions, including those resulting from autophagy alterations.
These neurodegenerative phenotypes are often studied in
the eye photoreceptor neurons, as this is the most accessible
and life-dispensable part of the ﬂy nervous system (Nisoli
et al., 2010; Napoletano et al., 2011). In this system we
were able to demonstrate the requirement for epg5 for pres-
ervation of neuronal cells during the ﬂy lifespan, suggesting
that the progressive loss of neuronal cells observed in the
ﬂy may be the basis for some of the neurological features
seen in EPG5-deﬁcient humans.
Conclusion
Consistent clinical, neuroradiological, and neuropatho-
logical ﬁndings suggest EPG5-related Vici syndrome as a
paradigm of a new class of multisystem disorders featuring
substantial overlap with other multisystem presentations, in
particular those due to primary glycosylation defects, mito-
chondrial disease, and lysosomal and glycogen storage dis-
orders. A number of similar conditions with overlapping
features have been described in association with defects
concerning intracellular trafﬁcking and lysosomal trans-
port, suggesting that disorders intricately linked in the
same pathways (in particular those concerning autophago-
some and lysosome biology) share a recognizable clinical
signature (Ebrahimi-Fakhari et al., 2015). Moreover, we
postulate that EPG5-related Vici syndrome is as much a
disorder of embryonic organ development as of degener-
ation. Evolution of neurodegenerative features over time
indicates an intriguing link between neurodevelopment
and neurodegeneration, also supported by features of
neurodegeneration in epg5-deﬁcient D. melanogaster, and
recent implication of other autophagy regulators in late-
onset neurodegenerative disease.
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